- Deciding which visits can safely move outside the site
- Supporting investigators with hybrid delivery
- Exploring what can be checked or verified remotely
- Integrating telemedicine into regulated studies
- Practical lessons from recent hybrid rare disease trials
- Common frustrations with sponsors
- What good collaboration looks like
- How sponsors can make studies easier to run
- Practical challenges that improve site performance
- How regulators are using real-world evidence
- What evidence sponsors should start generating now
- Regulatory expectations over the next 3-5 years
- Preparing for future submissions
